Compare Definium Therapeutics Inc. Common Shares (DFTX) vs Veeva Systems (VEEV) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Definium Therapeutics Inc. Common Shares vs Veeva Systems — how do they compare? Definium Therapeutics Inc. Common Shares trades at $36.32 (market cap $4.59B), while Veeva Systems trades at $287.36 (market cap $46.12B). The key difference: Veeva Systems is far larger — about 10× Definium Therapeutics Inc. Common Shares's market cap, and Veeva Systems is trading nearer its 52-week high, Definium Therapeutics Inc. Common Shares nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Definium Therapeutics Inc. Common Shares for 0 Days and Veeva Systems for 5 Days on average.
| DFTX | VEEV | |
|---|---|---|
Market Cap | $4.59B | $46.12B |
Volume | 2,103,937 | 921,537 |
Sector | Health | Technology |
52-Week High | $48.45 | $299.10 |
52-Week Low | $10.68 | $151.43 |
Typical Hold Time | 0 Days | 5 Days |
Enterprise Value | $3.55B | $39.03B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Definium Therapeutics Inc. Common Shares
Definium Therapeutics develops investigational treatments for psychiatric and neurological disorders. Formerly MindMed, it focuses on clinical-stage therapies based on novel psychoactive compounds.
Read more on DFTX →About Veeva Systems
Veeva Systems provides cloud software, data, and services for the life sciences industry. Its applications support functions across clinical research, regulatory operations, quality, safety, and commercial teams.
Read more on VEEV →
